1258595-14-0
1258595-14-0
Chemical Structure
LHC-165
- CAS No.: 1258595-14-0
- Formula:C29H32F2N3O7P
- Molecular Weight:603.55
IUPAC Name: 3-(5-amino-2-(4-(2-(3,3-difluoro-3-phosphonopropoxy)ethoxy)-2-methylphenethyl)benzo[f][1,7]naphthyridin-8-yl)propanoic acid
InChIKey: SDLWKRZBLTZSEL-UHFFFAOYSA-N
SMILES: NC1=C2C(C=C(CCC3=CC=C(OCCOCCC(F)(F)P(O)(O)=O)C=C3C)C=N2)=C4C(C=C(CCC(O)=O)C=C4)=N1
Biological Activity: LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LHC-165 | 98.0% | LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LHC-165 (Standard) | ≥98% | LHC-165 (Standard) is the analytical standard of LHC-165 (HY-111786). This product is intended for research and analytical applications. LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
